On June 20th, Nanolive has launched another ground-breaking tool in cell analysis: the LIVE Cytotoxicity Assay, an AI-powered digital assay with fluorescent labelling that monitors the responses of different cell lines in co-culture simultaneously.
For this event, we had the participation of several key opinion leaders from various pharmaceutical companies and institutions.
Watch the video below, where they share their thoughts on Nanolive’s technology.
Read our latest news
Label-free assessment of immunotherapies for liquid tumors
From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates for liquid tumors using live, label-free and advanced automated analysis of effector cell activity and function. Discover the case study data.
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…